Experimental Testing and Modeling of a Pneumatic Regolith Delivery System for ISRU

Excavating and transporting planetary regolith are examples of surface activities that may occur during a future space exploration mission to a planetary body. Regolith, whether it is collected on the Moon, Mars or even an asteroid, consists of granular minerals, some of which have been identified to be viable resources that can be mined and processed chemically to extract useful by-products, such as oxygen, water, and various metals and metal alloys. Even the depleted "waste" material from such chemical processes may be utilized later in the construction of landing pads and protective structures at the site of a planetary base. One reason for excavating and conveying planetary regolith is to deliver raw regolith material to in-situ resource utilization (ISRU) systems. The goal of ISRU is to provide expendable supplies and materials at the planetary destination, if possible. An in-situ capability of producing mission-critical substances such as oxygen will help to extend the mission and its success, and will greatly lower the overall cost of a mission by either eliminating, or significantly reducing, the need to transport the same expendable materials from the Earth. In order to support the goals and objectives of present and future ISRU projects, NASA seeks technology advancements in the areas of regolith conveying. Such systems must be effective, efficient and provide reliable performance over long durations while being exposed to the harsh environments found on planetary surfaces. These conditions include contact with very abrasive regolith particulates, exposure to high vacuum or dry (partial) atmospheres, wide variations in temperature, reduced gravity, and exposure to space radiation. Regolith conveying techniques that combine reduced failure modes and low energy consumption with high material transfer rates will provide significant value for future space exploration missions to the surfaces of the moon, Mars and asteroids. Pneumatic regolith conveying has demonstrated itself to be a viable delivery system through testing under terrestrial and reduced gravity conditions in recent years. Modeling and experimental testing have been conducted at NASA Kennedy Space Center to study and advance pneumatic planetary regolith delivery systems in support of NASA's ISRU project. The goal of this work is to use the model to predict solid-gas flow patterns in reduced gravity environments for ISRU inlet gas line allowing the eductor inlet gas flow to vary and depend on the flow pattern developed at the eductor as inferred by the experimental observations

An Unified Approach To Pseudo Scalar Meson Photoproductions Off Nucleons In The Quark Model

An unified approach to the pseudo scalar meson ($\pi, \eta$, and $K$) photoproduction off nucleons are presented. It begins with the low energy QCD Lagrangian, and the resonances in the s- and u- channels are treated in the framework of the quark model The duality hypothesis is imposed to limit the number of the t-channel exchanges. The CGLN amplitudes for each reaction are evaluated, which include both proton and neutron targets. The important role by the S-wave resonances in the second resonance region is discussed, it is particularly important for the $K, \eta$ and $\eta^\prime$ photoproductions.Comment: 31 pages in Latex fil

The Kaon-Photoproduction Of Nucleons In The Quark Model

In this paper, we develop a general framework to study the meson-photoproductions of nucleons in the chiral quark model. The S and U channel resonance contributions are expressed in terms of the Chew-Goldberger-Low-Nambu (CGLN) amplitudes. The kaon-photoproduction processes, $\gamma p\to K^+ \Lambda$, $\gamma p\to K^+ \Sigma^0$, and $\gamma p\to K^0\Sigma^+$, are calculated. The initial results show that the quark model provides a much improved description of the reaction mechanism for the kaon-photoproductions of the nucleon with less parameters than the traditional phenomenological approaches.Comment: 25 pages, 9 postscript figures can be obtained from the author

Pseudoscalar Glueball Mass: QCD vs. Lattice Gauge Theory Prediction

We study whether the pseudoscalar glueball mass in full QCD can differ from the prediction of quenched lattice calculations. Using properties of the correlator of the vacuum topological susceptibility we derive an expression for the upper bound on the QCD glueball mass. We show that the QCD pseudoscalar glueball is lighter than the pure Yang-Mills theory glueball studied in quenched lattice calculations. The mass difference between those two states is of order of $1/N_c$. The value calculated for the $0^{-+}$ QCD glueball mass can not be reconciled with any physical state observed so far in the corresponding channel. The glueball decay constant and its production rate in $J/\psi$ radiative decays are calculated. The production rate is large enough to be studied experimentally.Comment: 18 pages, LaTex fil

Effects of An Acute Increase in Atrial Pressure on Atrial Refractoriness in Humans

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/73199/1/j.1540-8159.1992.tb02954.x.pd

BcB_c spectroscopy

In the framework of potential models for heavy quarkonium the mass spectrum for the system ($\bar b c$) is considered. Spin-dependent splittings, taking into account a change of a constant for effective Coulomb interaction between the quarks, and widths of radiative transitions between the ($\bar b c$) levels are calculated. In the framework of QCD sum rules, masses of the lightest vector $B_c^*$ and pseudoscalar $B_c$ states are estimated, scaling relation for leptonic constants of heavy quarkonia is derived, and the leptonic constant $f_{B_C}$ is evaluated.Comment: IHEP 94-51, LATEX, 39 page

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to 300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of <15 ml per minute per 1.73 m 2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P<0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P<0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years

Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to &lt;90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], &gt;300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of &lt;15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P&lt;0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P&lt;0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years

BOREAS Level-0 ER-2 Aerial Photography

For BOReal Ecosystem-Atmosphere Study (BOREAS), the ER-2 and other aerial photography was collected to provide finely detailed and spatially extensive documentation of the condition of the primary study sites. The ER-2 aerial photography consists of color-IR transparencies collected during flights in 1994 and 1996 over the study areas

Petrophysical Properties of Twenty Drill Cores from the Los Azufres, Mexico, Geothermal Field

For this study we selected 20 drill cores covering a wide range of depths (400-3000 m), from 15 wells, that provide a reasonable coverage of the field. Only andesite, the largely predominant rock type in the field, was included in this sample. We measured bulk density, grain (solids) density, effective porosity and (matrix) permeability on a considerable number of specimens taken from the cores; and inferred the corresponding total porosity and fraction of interconnected total porosity. We characterized the statistical distributions of the measured and inferred variables. The distributions of bulk density and grain density resulted approximately normal; the distributions of effective porosity, total porosity and fraction of total porosity turned out to be bimodal; the permeability distribution resulted highly skewed towards very small (1 mdarcy) values, though values as high as 400 mdarcies were measured. We also characterized the internal inhomogeneity of the cores by means of the ratio (standard deviation/mean) corresponding to the bulk density in each core (in average there are 9 specimens per core). The cores were found to present clearly discernible inhomogeneity; this quantitative characterization will help design new experimental work and interpret currently available and forthcoming results. We also found statistically significant linear correlations between total density and density of solids, effective porosity and total density, total porosity and total density, fraction of interconnected total porosity and the inverse of the effective porosity, total porosity and effective porosity; bulk density and total porosity also correlate with elevation. These results provide the first sizable and statistically detailed database available on petrophysical properties of the Los Azufres andesites. 1 tab., 16 figs., 4 refs